INCREASED INCIDENCE OF INSULIN-DEPENDENT DIABETES MELLITUS IN PEDIATRIC RENAL TRANSPLANT PATIENTS RECEIVING TACROLIMUS (FK506)

    loading  Checking for direct PDF access through Ovid

Abstract

Background.

Use of tacrolimus (FK506), a potent immunosuppressive agent, has been reported to have a 10-20% incidence of insulin-dependent diabetes mellitus (IDDM) in adults, but the incidence of IDDM in pediatric renal transplant recipients treated with this agent is unknown. In this article, we report our single-center experience with FK506-induced IDDM in children.

Methods.

Five consecutive living related donor pediatric renal transplants were reviewed retrospectively.

Results.

All five patients developed IDDM lasting longer than 6 months. Mean follow-up time was 18.6 months.

Conclusions.

Pediatric patients may be at high risk for developing FK506-induced IDDM.

Related Topics

    loading  Loading Related Articles